Page last updated: 2024-08-16

imatinib and debromohymenialdisine

imatinib has been researched along with debromohymenialdisine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Addová, G; Boháč, A; Dobiaš, J; Hanquet, G; Murár, M; Šramel, P	1

Other Studies

1 other study(ies) available for imatinib and debromohymenialdisine

Article	Year
Novel CLK1 inhibitors based on N-aryloxazol-2-amine skeleton - A possible way to dual VEGFR2 TK/CLK ligands. European journal of medicinal chemistry, 2017, Jan-27, Volume: 126 Topics: Alternative Splicing; Amines; Binding Sites; Drug Discovery; Humans; Ligands; Oxazoles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Vascular Endothelial Growth Factor Receptor-2	2017

Article

Year

Novel CLK1 inhibitors based on N-aryloxazol-2-amine skeleton - A possible way to dual VEGFR2 TK/CLK ligands.

European journal of medicinal chemistry, 2017, Jan-27, Volume: 126

Topics: Alternative Splicing; Amines; Binding Sites; Drug Discovery; Humans; Ligands; Oxazoles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Vascular Endothelial Growth Factor Receptor-2

2017